Pfizer, Inc. (PFE) Q4 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Pfizer, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:05.881 Good day, everyone, and welcome to Pfizer's fourth quarter 2025 earnings conference call. 00:00:05.881 -- 00:00:10.669 Today's call is being recorded. At this time, I would like to turn the call over to Francesca 00:00:10.669 -- 00:00:15.236 DiMartino, Chief Investor Relations Officer and Senior Vice President. 00:00:15.236 -- 00:00:17.660 Please go ahead, ma'am. 00:00:17.660 -- 00:00:20.365 Good morning, and welcome to Pfizer's earnings call. 00:00:20.365 -- 00:00:23.723 I'm Francesca DiMartino, Chief Investor Relations Officer. 00:00:23.723 -- 00:00:26.868 On behalf of the Pfizer team, thank you for joining us. 00:00:26.868 -- 00:00:31.436 This call is being made available via audio webcast at Pfizer.com. 00:00:31.436 -- 00:00:35.903 Earlier this morning, we released our results for the fourth quarter and full year 2025 00:00:35.903 -- 00:00:40.510 via a press release that is available on our website at Pfizer.com. 00:00:40.510 -- 00:00:44.617 I'm joined today by Dr. Albert Bourla, our chairman and CEO, Dr. 00:00:44.617 -- 00:00:48.944 Chris Boshoff, our scientific officer, chief scientific officer, and Dave Denton, our 00:00:48.944 -- 00:00:54.055 CFO. Albert, Chris, and Dave have some prepared remarks, and we will then open the call 00:00:54.055 -- 00:00:59.263 for questions. Members of our leadership team will be available for the Q&A session. 00:00:59.263 -- 00:01:03.168 Before we get started, I want to remind you that we will be making forward-looking statements 00:01:03.168 -- 00:01:06.593 and discussing certain non-GAAP financial measures. 00:01:06.593 -- 00:01:10.378 I encourage you to read the disclaimers in our slide presentation, the press release 00:01:10.378 -- 00:01:15.064 we issued this morning, and the disclosures...